Trinity Biotech (TRIB) Other Accumulated Expenses (2009 - 2024)

Trinity Biotech has disclosed Other Accumulated Expenses across 16 years of filings, most recently posting $3.0 million for Q4 2024.

• Other Accumulated Expenses for Q4 2024 came in at $3.0 million, up 4.15% year-over-year; the trailing twelve-month figure through Dec 2024 was $3.0 million (up 4.15% YoY), and the FY2024 annual result was $3.0 million, up 4.15% from the prior year.
• Other Accumulated Expenses came in at $3.0 million for Q4 2024 at Trinity Biotech, up from $1.8 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $69.3 million in Q4 2020 to a low of $1.8 million in Q1 2024.
• The 5-year median for Other Accumulated Expenses is $13.0 million (2022), against an average of $17.0 million.
• Across the five-year window, Other Accumulated Expenses increased 7.87% in 2020 and slumped 83.54% in 2024, its largest moves.
• Trinity Biotech's Other Accumulated Expenses stood at $69.3 million in 2020, then dropped by 0.79% to $68.8 million in 2021, then slumped by 82.16% to $12.3 million in 2022, then tumbled by 76.61% to $2.9 million in 2023, then gained by 4.15% to $3.0 million in 2024.
• The last three Other Accumulated Expenses figures came in at $3.0 million (Q4 2024), $1.8 million (Q3 2024), and $1.8 million (Q2 2024), per Business Quant data.